LEADER 01407oam  2200373Ia 450 
001 9910699134003321
005 20230902162256.0
035   $a(CKB)5470000002400558
035   $a(OCoLC)325066321
035   $a(EXLCZ)995470000002400558
100   $a20090518d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eimplementing a collection program for source plasma containing disease-associated and other immunoglobulin G (IgG) antibodies
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2006]
215   $ai, 4 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 18, 2009).
300   $a"August 2006."
517   $aGuidance for industry 
606   $aBlood donors$xGovernment policy$zUnited States
606   $aPlasma engineering$xGovernment policy$zUnited States
615  0$aBlood donors$xGovernment policy
615  0$aPlasma engineering$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910699134003321
996   $aGuidance for industry$93434577
997   $aUNINA